You are here
Tetragenetics, Inc.
UEI: E4V5EMGNKBY5
# of Employees: 3
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Expanding the use of Tetrahymena as a protein expression platform
Amount: $1,689,529.00DESCRIPTION provided by applicant Tetragenetics Inc an early stage biotechnology company in Cambridge MA has developed a powerful cross cutting technology for the overexpression of eukaryotic mem ...
SBIRPhase II2015Department of Health and Human Services National Institutes of Health -
Novel methods for high-level expression of aglycosylated or fully glycosylated mo
Amount: $177,636.00DESCRIPTION (provided by applicant): The potential impact of monoclonal antibodies on human health through the treatment of a wide range of human diseases has led to accelerated development of these m ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
Genomes-To-Life (GTL) and Related Biotechnologies; Innovative Protein Production Technology in Microbes and Plants
Amount: $750,000.00Genetically engineered proteins are now being used in a wide range of critically important applications, including bioremediation, alternative energy production, and the treatment and prevention of hu ...
SBIRPhase II2009Department of Energy -
Genomes-To-Life (GTL) and Related Biotechnologies; Innovative Protein Production Technology in Microbes and Plants
Amount: $100,000.00Current manufacturing platforms are adequate for large-scale expression of a wide range of genetically engineered proteins, which are of interest to the DOE¿s Genomes-to-Life program. Nevertheless, ...
SBIRPhase I2008Department of Energy -
Tetrahymena thermophila as a Novel Recombinant and Engineered Protein Accumulation System (REPAS)
Amount: $750,000.00Recombinant proteins are critically important in a wide range of applications that extend from the treatment of human and animal disease, to chemical and biological defense. Production of genetically ...
STTRPhase II2007Department of Defense Army -
Recombinant and Engineered Protein Accumulation System (REPAS)
Amount: $100,000.00To fully realize the benefits of genetically engineered proteins, manufacturing costs and development time must be significantly reduced. Technologies that combine robust expression, and inexpensive m ...
STTRPhase I2006Department of Defense Army -
Overexpression of membrane proteins in Tetrahymena
Amount: $99,128.00DESCRIPTION (provided by applicant): These studies are intended to establish Tetrahymena as an alternative expression system for use in high-throughput structural studies, and for large-scale producti ...
STTRPhase I2006Department of Health and Human Services National Institutes of Health -
Overexpression of membrane proteins in Tetrahymena
Amount: $99,128.00DESCRIPTION (provided by applicant): These studies are intended to establish Tetrahymena as an alternative expression system for use in high-throughput structural studies, and for large-scale producti ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health -
Marine Mammal Vaccines
Amount: $100,000.00Identify an animal model that shows clinical signs of disease. With such a model, we can begin to test the vaccine and obtain at least preliminary evidence for its efficacy. This would provide the i ...
SBIRPhase I2005Department of Defense Navy